Literature DB >> 30027207

Probiotics to Prevent Clostridium difficile Infection in Patients Receiving Antibiotics.

Joshua Z Goldenberg1,2, Dominik Mertz3, Bradley C Johnston4.   

Abstract

CLINICAL QUESTION: In adults and children prescribed antibiotics, is co-administration of a probiotic associated with a lower risk of symptomatic Clostridium difficile infection without an increase in adverse events? BOTTOM LINE: Moderate-quality evidence suggests that probiotics are associated with a lower risk of C difficile infection and very low-quality evidence suggests that probiotics are associated with fewer adverse events vs placebo or no treatment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30027207     DOI: 10.1001/jama.2018.9064

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  19 in total

Review 1.  Probiotics in the next-generation sequencing era.

Authors:  Jotham Suez; Niv Zmora; Eran Elinav
Journal:  Gut Microbes       Date:  2019-04-05

Review 2.  Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.

Authors:  Ziying Zhang; Haosheng Tang; Peng Chen; Hui Xie; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2019-10-12

3.  Evaluation of the therapeutic effect and dose-effect of Bifidobacterium breve on the primary Clostridioides difficile infected mice.

Authors:  Jingpeng Yang; Hong Yang
Journal:  Appl Microbiol Biotechnol       Date:  2021-11-09       Impact factor: 4.813

4.  Antagonistic activity of selenium-enriched Bifidobacterium breve against Clostridioides difficile.

Authors:  Wen Rui; Chenyu Gu; Huiru Zhang; Xinwei Liao; Xinyu Zhao; Yujia Xu; Jingpeng Yang
Journal:  Appl Microbiol Biotechnol       Date:  2022-08-13       Impact factor: 5.560

5.  Activation of a passive, mesoporous silica nanoparticle layer through attachment of bacterially-derived carbon-quantum-dots for protection and functional enhancement of probiotics.

Authors:  Hao Wei; Wei Geng; Xiao-Yu Yang; Jeroen Kuipers; Henny C van der Mei; Henk J Busscher
Journal:  Mater Today Bio       Date:  2022-05-17

6.  Toward more rigorous and informative nutritional epidemiology: The rational space between dismissal and defense of the status quo.

Authors:  Andrew W Brown; Stella Aslibekyan; Dennis Bier; Rafael Ferreira da Silva; Adam Hoover; David M Klurfeld; Eric Loken; Evan Mayo-Wilson; Nir Menachemi; Greg Pavela; Dale Schoeller; Colby J Vorland; Leah D Whigham; David B Allison
Journal:  Crit Rev Food Sci Nutr       Date:  2021-10-22       Impact factor: 11.208

7.  Escherichia coli Colonization of Intestinal Epithelial Layers In Vitro in the Presence of Encapsulated Bifidobacterium breve for Its Protection against Gastrointestinal Fluids and Antibiotics.

Authors:  Lu Yuan; Hao Wei; Xiao-Yu Yang; Wei Geng; Brandon W Peterson; Henny C van der Mei; Henk J Busscher
Journal:  ACS Appl Mater Interfaces       Date:  2021-04-01       Impact factor: 9.229

8.  Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model.

Authors:  Jingpeng Yang; Hong Yang; Lingtong Meng
Journal:  Microbiol Spectr       Date:  2022-03-21

9.  Efficacy and safety of probiotics in eradicating Helicobacter pylori: A network meta-analysis.

Authors:  Xiaoguang Shi; Junhong Zhang; Lingshan Mo; Jialing Shi; Mengbin Qin; Xue Huang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

10.  Bacterial Characteristics in Intestinal Contents of Antibiotic-Associated Diarrhea Mice Treated with Qiweibaizhu Powder.

Authors:  Huaying Hui; Yi Wu; Tao Zheng; Sainan Zhou; Zhoujin Tan
Journal:  Med Sci Monit       Date:  2020-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.